GLP-2 formulations
US7056886B2 · kind B2 · utility
24Cited by
6References
75Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 29, 2000 |
| Grant date | Jun 6, 2006 |
| Priority date | — |
| Expiry date | Sep 18, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to formulations of GLP-2 peptides and analogs thereof exhibiting superior stability following storage and/or exposure to elevated temperatures. The GLP-2 compositions comprise a GLP-2 peptide or an analog thereof, a phosphate buffer, L-histidine, and mannitol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.